MedPath
NMPA Approval

Dapagliflozin Tablets

国药准字H20253906

April 15, 2025

Drug Information

达格列净片

片剂

10mg(按C₂₁H₂₅ClO₆计)

化学药品

April 15, 2025

Company Information

Applicant Company

河南省驻马店市清河大道6号

Manufacturing Company

北辰科技园区华实道88号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

达格列净片 - NMPA 批准文号 | MedPath